Enzo (ENZ): Earnings per share for the last twelve months

Official company branding of Enzo Biochem (ENZ)

The use of cloud IT solutions minimizes infrastructure risks, and the GURU.Markets terminal displays the rolling annual earnings per share, where -0.41 captures the current state of the parameter for Enzo Biochem, Inc. (ENZ). Business stability relies on internal reagent synthesis and strict quality control. An extensive array of diagnostic patents and licensing rights for unique medical methodologies generates additional income.

ENZ (Enzo Biochem, Inc.) Net earnings per one share for the last twelve months history from 07/04/2022 to 04/26/2025
Flagship merchandise of Enzo

The operational efficiency of molecular biologists and compliance specialists at Enzo Biochem, Inc. (ENZ) directly impacts the net income per share TTM. This indicator reflects the issuer's aggregate income over a rolling year, distributed across the total volume of shares. The metric demonstrates the actual equity return, adjusted for the impact of issuance. Growth in this figure above the weighted average cost of capital (WACC) confirms value creation. The stability of this trend characterizes the fundamental resilience of the business.

Competing companies

Agilent Technologies - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters questdiagnostics.com DGX|Illumina (ILMN) - Earnings per share for the last twelve months|EXAS - Net earnings per share for the last four quarters|RVTY (PerkinElmer) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Bio-Rad Corp BIO|Earnings per share for the last twelve months Anbio Biotechnology (NNNN)|soterahealth.com - Earnings per share for the last 12 months|QuidelOrtho Corporation - Net earnings per share for the last 12 months|OPK (OPKO Health Inc) - Earnings per one share for the last 12 months|CDNA - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Maravai|FLGT (Fulgent Genetics, Inc.) - Net earnings per share for the last 12 months|fluidigm.com - Earnings per share for the trailing year|CTKB (Cytek Biosciences) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months OSUR|Net earnings per share (EPS TTM) XGN|Net earnings per share for the last four quarters MDxHealth, Inc.|Earnings per share for the last twelve months Lucid Diagnostics Inc. LUCD|Prenetics Global Limited (PRE) - Net earnings per one share for the last twelve months|Insight Molecular - Net earnings per share (EPS TTM)|Trinity Biotech plc (TRIB) - Net earnings per share for the last 12 months|PRPH: Net earnings per share (EPS TTM)|Ainos Corporation - Earnings per share for the trailing year|CODX (Co-Diagnostics, Inc.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months heartsciences.com HSCS|Earnings per share for the last twelve months Biomerica (BMRA)|Net earnings per share for the last 12 months cardiodiagnosticsinc.com CDIO|Onconetix Corp - Net earnings per share for the last 12 months|Earnings per share for the trailing year VRAX|Bluejay Diagnostics - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters aspirawh.com AWH|Accelerate Diagnostics, Inc. (AXDX) - Earnings per share for the last twelve months|Earnings per share for the last 12 months CNTG|FRES (Fresh2 Group Ltd) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months GTG Labs (GENE)|Net earnings per share for the last 12 months ME (23andMe Holding Co.)|Net earnings per share for the last four quarters psychemedics.com